Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES

Young‐Hyuck Im, Bülent Karabulut, Keun Seok Lee, Byeong‐Woo Park, Aditya Adhav, Havva Yeşil Çınkır, Hikmat Abdel‐Razeq, Yuan-Ching Chang, Sercan Aksoy, Seock‐Ah Im, Joon Jeong, Y.S. Chae, James Bowles, Khémaies Slimane, Hong-Ling Xue, Sung‐Bae Kim